Schedule 13D ownership disclosure
Amylyx Pharmaceuticals Inc
Security class unavailable · CUSIP: 03237H101
Event date: 2023-08-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.8600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-215139
- Form type
- SC 13D
- Filer
- Amylyx Pharmaceuticals, Inc.
- CIK
- CIK 1658551
- Filed
- Aug 17, 2023
- Reporting period
- Aug 15, 2023
- Description
- Schedule 13D beneficial ownership